HeartBeam, Inc. (BEAT)

NASDAQ: BEAT · Real-Time Price · USD
1.810
-0.069 (-3.67%)
May 8, 2025, 4:00 PM - Market closed
-3.67%
Market Cap 61.04M
Revenue (ttm) n/a
Net Income (ttm) -19.45M
Shares Out 33.73M
EPS (ttm) -0.73
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 11,001
Open 1.850
Previous Close 1.879
Day's Range 1.810 - 1.870
52-Week Range 1.450 - 3.480
Beta -0.58
Analysts Buy
Price Target 8.00 (+341.99%)
Earnings Date May 13, 2025

About BEAT

HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California. [Read more]

Sector Healthcare
IPO Date Nov 11, 2021
Employees 21
Stock Exchange NASDAQ
Ticker Symbol BEAT
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to one analyst, the rating for BEAT stock is "Buy" and the 12-month stock price forecast is $8.0.

Price Target
$8.0
(341.99% upside)
Analyst Consensus: Buy
Stock Forecasts

News

HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio.

2 days ago - Business Wire

HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth.

3 days ago - Business Wire

HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time.

7 days ago - Business Wire

HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology.

9 days ago - Business Wire

HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation

SANTA CLARA, Calif. & NEW YORK--(BUSINESS WIRE)--HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation.

14 days ago - Business Wire

HeartBeam, Inc. (BEAT) Q4 2024 Earnings Call Transcript

HeartBeam, Inc. (NASDAQ:BEAT) Q4 2024 Results Conference Call March 13, 2025 4:30 PM ET Company Participants Rob Eno - Chief Executive Officer Tim Cruickshank - Chief Financial Officer Operator Greet...

2 months ago - Seeking Alpha

HeartBeam Reports Fourth Quarter and Full Year 2024 Results

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports Fourth Quarter and Full Year 2024 Results.

2 months ago - Business Wire

HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 16-21, 2025

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 17-21, 2025.

2 months ago - Business Wire

HeartBeam to Host Fourth Quarter Full Year 2024 Results Conference Call on Thursday, March 13, 2025 at 4:30 p.m. Eastern Time

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host Fourth Quarter Full Year 2024 Results Conference Call on Thursday, March 13, 2025 at 4:30 p.m. Eastern Time.

2 months ago - Business Wire

HeartBeam Announces Exercise and Closing of Underwriter's Over-Allotment Option for Public Offering of Common Stock

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Exercise and Closing of Underwriter's Over-Allotment Option for Public Offering of Common Stock.

2 months ago - Business Wire

HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock.

3 months ago - Business Wire

HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software.

3 months ago - Business Wire

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference.

4 months ago - Business Wire

HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology.

5 months ago - Business Wire

HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference.

6 months ago - Business Wire

HeartBeam, Inc. (BEAT) Q3 2024 Earnings Call Transcript

HeartBeam, Inc. (NASDAQ:BEAT) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Rob Eno - Chief Executive Officer Branislav Vajdic - President and Founder Tim Cruicksh...

6 months ago - Seeking Alpha

HeartBeam Reports Third Quarter 2024 Results

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports Third Quarter 2024 Results.

6 months ago - Business Wire

HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time.

6 months ago - Business Wire

HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards.

7 months ago - Business Wire

HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization.

7 months ago - Business Wire

HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist.

8 months ago - Business Wire

HeartBeam Names Timothy Cruickshank as Chief Financial Officer

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Names Timothy Cruickshank as Chief Financial Officer.

8 months ago - Business Wire

HeartBeam, Inc. (BEAT) Q2 2024 Earnings Call Transcript

HeartBeam, Inc. (NASDAQ:BEAT) Q2 2024 Earnings Conference Call August 14, 2024 4:30 PM ET Company Participants Branislav Vajdic - Founder and CEO Rob Eno - President Ravi Malhotra - Senior Director, ...

9 months ago - Seeking Alpha

HeartBeam Reports Second Quarter 2024 Results

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports Second Quarter 2024 Results.

9 months ago - Business Wire

HeartBeam to Host Second Quarter 2024 Results Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host Second Quarter 2024 Results Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time.

10 months ago - Business Wire